Standardized kidney biopsy protocol is safe in high-risk patients
A prospective study presented at ASN Kidney Week 2026 demonstrates that the ROCKY standardized protocol allows high-risk patients to undergo kidney biopsies safely. The protocol significantly reduces complication rates, proving that traditional risk factors like age or anticoagulant use do not necessarily preclude safe procedures.
Why it matters
This research could expand access to essential diagnostic procedures for vulnerable patient populations previously deemed too high-risk for biopsy.
edited by Sadie Harley , reviewed by Andrew Zinin
This article has been reviewed according to Science X's editorial process and policies . Editors have highlighted the following attributes while ensuring the content's credibility:
Add to Preferred Sources Credit: Unsplash/CC0 Public Domain Results from a prospective study reveal that with standardized precautions, even high-risk patients may safely undergo a kidney biopsy, a cornerstone of kidney diagnostics that is often perceived as dangerous in certain vulnerable patient populations. The findings were presented at ASN Kidney Week 2026, Oct. 22–25.
The research involved the use of the ROCKY standardized protocol (Renal-biopsy Optimized Care and Knowledge Yielding safety), which combines structured checkpoints to maximize the diagnostic utility of a kidney biopsy while minimizing its associated risks, such as bleeding.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in